Dicronis

Patients treated for cancer have suffered enough. However, 10% of them are then confronted with a chronic complication of the therapies, manifested by the progressive swelling of a limb, known as lymphedema. To date, lymphedema is diagnosed by the assessment of the circumference or the volume of the arm over time. This is not efficient as it requires the disease to progress until a stage it can be detected. At Dicronis, we strive at improving the quality of life of cancer treated patients by ensuring the earliest possible detection of lymphedema by assessing the lymphatic activity in a simple, painless and home-based manner. Our Lymphit is the first tracker for the lymphatic activity, featuring a unique combination of microarray patches technology and optical wearable systems.